Results 41 to 50 of about 496 (136)

Drainage of malignant ascites: patient selection and perspectives

Cancer Management and Research, 2017
Maciej Stukan Department of Gynecologic Oncology, Gdynia Oncology Center, Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia, Poland Abstract: Malignant ascites (MA) is a sign of advanced cancer and poor prognosis.
Stukan M
doaj  

Peritoneovenous shunts in the management of malignant ascites

Journal of British Surgery, 1983
Abstract Peritoneovenous shunts have been inserted into 26 patients to control malignant ascites. All benefitted and most required no further paracentesis until death from progressive malignancy. Shunt blockage, which is the major problem at present, occurred in 8 patients. Five patients suffering from far advanced malignancy died within
R G, Souter, D, Tarin, M G, Kettlewell
openaire   +2 more sources

Peritoneovenous shunting for ascites in cancer patients

Journal of British Surgery, 1980
Summary Twenty patients with malignant ascites were treated by insertion of a peritoneovenous shunt. Twelve had a Le Veen shunt, 7 a Denver shunt and 1 patient had a Le Veen shunt subsequently replaced by a Denver shunt. Overall survival was poor, which reflects the advanced stage of the patients' disease.
openaire   +2 more sources

Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement. [PDF]

Semin Intervent Radiol, 2017
Yarmohammadi H, Getrajdman GI.
europepmc   +1 more source

Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites. [PDF]

Ann R Coll Surg Engl, 2017
Hariharan D, Wilkes EA, Aithal GP, Travis SJ, Lobo DN.   +4 more
europepmc   +1 more source

Ascites With Honeycombed Appearance. [PDF]

Gastro Hep Adv, 2023
Shionoya K, Uojima H.
europepmc   +1 more source

Successful Treatment of Ascites using a Denver^® Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome. [PDF]

Intern Med, 2016
Kogiso T, Hashimoto E, Ito T, Hara T, Ikarashi Y, Kodama K, Taniai M, Torii N, Yoshinaga K, Morita S, Takahashi Y, Tanaka J, Sakai S, Yamamoto M, Tokushige K.   +14 more
europepmc   +1 more source

Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report. [PDF]

Oncol Lett, 2016
Shigeto K, Kawaguchi T, Niizeki T, Kunitake Y, Takedatsu H, Tonan T, Fujimoto K, Tanaka M, Abe T, Naito H, Torimura T.   +10 more
europepmc   +1 more source

Prognostic factors for peritoneovenous shunt placement for refractory ascites in liver cirrhosis. [PDF]

World J Gastroenterol
Hamaguchi A, Ueda J, Taniai N, Yoshioka M, Matsushita A, Mizutani S, Kawano Y, Shimizu T, Kanda T, Murokawa T, Takata H, Furuki H, Aoki Y, Kawashima M, Irie T, Ono T, Haruna T, Yoshimori D, Yoshida H.   +18 more
europepmc   +1 more source

Right-sided endocarditis secondary to a peritoneovenous shunt. [PDF]

Can J Cardiol, 2010
Higgins J, Shayan H, Fradet G.
europepmc   +1 more source